OraVerse: Six wholesalers do not hold an establishment license for sale of the product in Canada
Brand(s)
Last updated
Summary
Product
Phentolamine Mesylate
Issue
Health products - Establishment/Site licensing
What to do
Consult your health care professional if you have any health concerns.
Distribution
Alberta
Ontario
Quebec
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
OraVerse |
Phentolamine mesylate |
DIN 2421666 |
Solution |
n/a |
D03743BB, D03743BD, D04182BA, D04182BD, D04182BF |
Issue
Six wholesalers that received product from the regulated party do not hold an establishment license for sale of the product in Canada.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Septodont (Novocol Pharmaceutical of Canada Inc.)
25 Wolseley Court, Cambridge, ON, N1R 6X3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
Ontario
Quebec
Recall class
Type III
Identification number
RA-74509
Get notified
Receive notifications for new and updated recalls and alerts by category.